John C English
Overview
Explore the profile of John C English including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1001
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Enfield K, Marshall E, Anderson C, Ng K, Rahmati S, Xu Z, et al.
Nat Commun
. 2019 Nov;
10(1):5438.
PMID: 31780666
Gene function in cancer is often cell type-specific. The epithelial cell-specific transcription factor ELF3 is a documented tumor suppressor in many epithelial tumors yet displays oncogenic properties in others. Here,...
12.
Goobie G, Sirrs S, Yee J, English J, Bergeron C, Nador R, et al.
Respir Med Case Rep
. 2019 Jul;
28:100893.
PMID: 31334026
Background: Gaucher disease type 1 (GD1) is a lysosomal storage disease rarely resulting in end stage pulmonary hypertension (PH) and interstitial lung disease. There have only been two previous case...
13.
Alwelaie Y, Deyell R, Nadel H, Tucker T, Laskin J, Rassekh S, et al.
J Thorac Oncol
. 2019 May;
14(6):e132-e135.
PMID: 31122568
No abstract available.
14.
Enfield K, Martin S, Marshall E, Kung S, Gallagher P, Milne K, et al.
J Immunother Cancer
. 2019 Jan;
7(1):13.
PMID: 30651131
Background: The tumor microenvironment (TME) is a complex mixture of tumor epithelium, stroma and immune cells, and the immune component of the TME is highly prognostic for tumor progression and...
15.
Grewal J, Morisset J, Fisher J, Churg A, Bilawich A, Ellis J, et al.
Ann Am Thorac Soc
. 2019 Jan;
16(4):455-462.
PMID: 30608873
Rationale: The interstitial lung disease (ILD) specialists in Vancouver participate in a multidisciplinary discussion (MDD) that is primarily used internally for patients seen by these specialists. The MDD is also...
16.
Tammemagi M, Schmidt H, Martel S, McWilliams A, Goffin J, Johnston M, et al.
Lancet Oncol
. 2017 Oct;
18(11):1523-1531.
PMID: 29055736
Background: Results from retrospective studies indicate that selecting individuals for low-dose CT lung cancer screening on the basis of a highly predictive risk model is superior to using criteria similar...
17.
Cressman S, Peacock S, Tammemagi M, Evans W, Leighl N, Goffin J, et al.
J Thorac Oncol
. 2017 May;
12(8):1210-1222.
PMID: 28499861
Introduction: Lung cancer risk prediction models have the potential to make programs more affordable; however, the economic evidence is limited. Methods: Participants in the National Lung Cancer Screening Trial (NLST)...
18.
Tsai A, English J, Murphy D, Sin D
Respirol Case Rep
. 2016 Dec;
5(2):e00211.
PMID: 27999676
Diffuse pulmonary ossification (DPO) is a rare disease with unknown pathogenesis, clinical manifestations, and treatment options. This report describes the diagnosis of DPO in an otherwise healthy 26-year-old man with...
19.
Marshall E, Ng K, Kung S, Conway E, Martinez V, Halvorsen E, et al.
Mol Cancer
. 2016 Oct;
15(1):67.
PMID: 27784305
Lung cancer is a leading cause of cancer-related deaths worldwide. Lung cancer risk factors, including smoking and exposure to environmental carcinogens, have been linked to chronic inflammation. An integral feature...
20.
Hashisako M, Tanaka T, Terasaki Y, Uekusa T, Achcar R, Aswad B, et al.
Arch Pathol Lab Med
. 2016 Sep;
140(12):1375-1382.
PMID: 27610646
Context: - The histopathologic criteria for idiopathic pulmonary fibrosis were revised in the American Thoracic Society/European Respiratory Society/Japan Respiratory Society/Latin American Thoracic Association guidelines in 2011. However, the evidence of...